vTv Therapeutics Inc (VTVT) Quote

vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

Cowboys2275: You Are Really A Special Cowboy!
https://stocktwits.com/cowboys2275/message/558967191

There will be More interest in VTVT!

https://zolmax.com/investing/vtv-therapeutics-inc-nasdaqvtvt-sees-large-increase-in-short-interest/9990102.html

American Bulls: Buy Signal!
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=VTVT

VTVT new 52 week low

$VTVT- 👆Up 16% Pre-Market/Current Price $0.78
👉Cantex Pharmaceuticals Publishes Article in npj Breast Cancer Highlighting Role of RAGE Inhibition to Prevent Metastasis in Triple-Negative Breast Cancer
👉Originally developed for Alzheimer's disease by vTv

2 week long runs in past on news and this is awesome news

Zero borrow and not optionable,low float target $4,insider trans up 145%

Zero borrow and not optionable,low float target $4,insider trans up 145%

https://finviz.com/quote.ashx?t=VTVT&ty=c&ta=1&p=d

I guess I spoke too soon.

Wow, we closed over 70 cents!

Because the company keeps spending and raising money without achieving anything.

Why, so difficult to get over 70 cents?

What's with the knuckleheads that are trading pre and post market?

https://stockcharts.com/h-sc/ui?s=VTVT&p=D&yr=0&mn=6&dy=0&id=p38090673899

Filled open gap .62 this morning!

$VTVT Huge Vol Alert

@bc9114 The $12.5m ( 5,193,187 shares) in shares distribution to G42 Healthcare were dilutive shares resulting in a increase in total outstanding shares from 90,036,637 to 95,229,824. The float will remain at 30,346,158 because G42 Healthcare will become an affiliate in the next 30 days.

“Lock-Up Period” means the period from the date of this Agreement until December 31, 2024 (or, if earlier, the date of receipt of FDA Approval). I love this Lock-Up Period : ) which is located on page 5.

These particular shares are classified as Unregistered Securities that orginated from the LPC Agreement which had $35.9 remaining available as of March 31st, 2022 & as a result of the G42 Healthcare Partnership the remaining availability under the LPC Agreement is now at $23.4m.

Common Stock Purchase Agreement: (Unregistered Securities)
sec.gov/Archives/edgar/data...

In the next 30 days Vtv's board will increase to 6 & will add
Dr. Fahed Al Marzooqi the COO of G42 Healthcare.

Read today's news it already happened at $2.41 per share.

What a good talk ....when is offering

We churned over the float but those who bought premarket up to $1.18 panic sold on the red open and the rest of the day others panic sold red down. Bottom line the 25-million-dollar investment is huge. We should be up a couple dollars. I am patient. We have more news on the way.
VTVT: This could run-up nicely today, behind substantive news of late and a $5.00 price prediction.

What going on here bulls ....just bought 5000 shares need info

Yes, I read that filing earlier!

New SEC Filing: 8-K Material Agrmt - vTv Therapeutics Inc. (0001641489) May 31


Item 1.01Entry into a Material Definitive Agreement Common Stock Purchase Agreement On May 31, 2022, vTv Therapeutics Inc. (the "Company") and G42 Investments AI Holding RSC Ltd, a private limited company ("G42 Investments"), entered into a common stock purchase agreement (the "Purchase Agreement"), pursuant to which the Company agreed to sell to G42 Investments 10,386,274 shares of the Company's Class A common stock, par value $0.01 per share (the "Common Stock" and such shares, the "Closing Shares") at a price per share of approximately $2.41, for an aggregate purchase price of $25,000,000, which was paid (i) $12,500,000 in cash at the closing of the transaction and (ii) $12,500,000 in the (...)

marketnewswire.live/index.p...

News

vTv Therapeutics Announces Entry Into Agreements That Include $25M Investment By G42 Investments AI Holding RSC
6:56 am ET June 1, 2022 (Benzinga) Print
vTv Therapeutics Inc. (NASDAQ:VTVT) today announced entry into agreements that include a $25 million investment by G42 Investments AI Holding RSC Ltd ("G42 Investments"). Under the terms of the agreements, G42 Investments acquired 10,386,274 shares of Class A Common Stock of vTv at an issue price of $2.407 per share, with $12.5 million paid in cash at closing, and the remaining amount of $12.5 million payable on May 31, 2023. The agreements also provide for the potential issuance of $30 million in additional shares of Class A Common Stock to G42 Investments (or cash in lieu of such issuance at the option of G42 Investments) if the United States Food and Drug Administration (the "FDA") approves the marketing and sale of a pharmaceutical product containing TTP399, a liver selective glucokinase activator, as the active ingredient for treatment of type 1 diabetes in the United States. The agreements set forth the terms under which vTv and an affiliate of G42 plan to collaborate on clinical trials for pharmaceutical products that contain TTP399, including G42's affiliate funding a portion of the Phase 3 clinical trials for TTP399, and vTv granting G42's affiliate an exclusive license to develop and commercialize pharmaceutical products containing TTP399 in certain territories outside of the United States and the European Union.

"We have focused substantial energy and resources on TTP399 since obtaining Breakthrough Therapy designation from the FDA in April 2021 and are thrilled to welcome a partner to work with us to accelerate the development and potential approval and commercialization of this treatment. G42 Healthcare brings a unique combination of strong commitment to the development of new impactful drugs and treatments, as demonstrated by their success and their leadership on COVID-19 testing and other product and service offerings in the healthcare spectrum, and substantial resources, making them an ideal partner for this program. This investment into vTv will fund a substantial portion of our Phase 3 clinical trials for TTP399 in the United States and the collaboration with G42 will fund certain of the Phase 3 clinical trials that will be conducted in other territories. We are excited to partner with the G42 Healthcare team as we launch our Phase 3 clinical trials and work together towards approval and commercialization of this treatment for type 1 diabetes," said Rich Nelson, Interim Chief Executive Officer of vTv.

Dr. Fahed Al Marzooqi, the Chief Operating Officer of G42 Healthcare, noted that "We have a deep commitment to collaborating with international organizations to share our knowledge and expertise in the consumer and clinical health spectrum and we look forward to working together with vTv to further develop and commercialize this important treatment. As we move ahead, we will continue to join forces with the world's best to innovate and invest in science and create the next wave of medicines to future-proof the health of nations."

A more detailed description of the agreements is set forth in vTv's Current Report on Form 8-K filed with the SEC. The Stock Purchase Agreement is attached to the Current Report on Form 8-K and the Collaboration and License Agreement will be filed with vTv's Quarterly Report on Form 10-Q for the second quarter.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor will there be any sale of these securities in any jurisdiction in which such offer solicitation or sale are unlawful prior to registration or qualification under securities laws of any such jurisdiction.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Or drop big

$VTVT
$VTVT Licking my chops with this chart..looks like $1 could be tested soon here.. just added to the Post Masters Telegram Room watchlist..we deliver!https://t.co/qZaQQOjnVVhttps://t.co/1HSlQfNws7 pic.twitter.com/SHqV52fAbw— Tommy Boy Trader (@QuabbinR) February 20, 2022

VTVT: This could run-up nicely today, behind substantive news of late and a $5.00 price prediction.

Really not till the start of 2022....but you never know when they'll drop a biggie

I am surprised this has not gotten more traction and visibility after releasing good trial data.

The Type 1 diabetes market is huge.

Any catalysts in the near term to help out?

Murocman

Too cheap to ignore here !

DWAC.....craziness

Likely because they are woefully behind on their financial filings.

Murocman

Well look at ADMP......they get FDA approval and the stock sells off......ya never know. GL with your trades...

P2 trials planned to initiate in 2022. I can’t see those increasing $VTVT as just adding more cost and likely more dilution.

The price of $VTVT going up is linked to the success of those trials.

I might invest at some point before readout if I think the risk/reward looks attractive. Need to see P2 trial protocols first.

Just need it to get past $3 over the next year. Think that's very doable. ITRM and ADMP couple others I'm watching.

Most of his shares were bought above $4. He recently bought 635,000 @ $1.60. I'm closing in on 100,000 shares. Hope I didn't make a mistake here.... Their trials haven't been very successful lately , and recently raised the O/S to 200M shares, which is still very low for a buck stock. ~ You have any other pharm plays that are ripe ? TIA.....

Perelman has years ago signed an agreement with vTv funding them on demand by buying the shares they issue.

Insider buying on that basis doesn’t tell you very much other than perhaps Perelman may be a sucker holding a big bag.

It seems he owns about 80% of the company. Not sure how many shares he owns....couldn't find that number on insider trades...

You like this thing Invest2014 ? Right now looks bad.....but 2022 is gonna be huge. Why not accum now...and put in a drawer for a year. No doubt this will bust $5 next year. Been picking up all these $1.40s..New CEO.....inside buying ....lots of things going on here. Huge pipeline...Not just one and done drug. Picking up this and SYN for a long hold.

It seems you can have most of the $VTVT that Perelman doesn’t own.

Almost filled up.

Bye buy bye buy

What a turd

I'll be able to buy that new Range Rover I've been looking at.....with cash !

Lol.....hi 1plus1....yes....this is shit right now.....That's why I'm accumulating this for a year from now. Insiders buying in this range...and not just teaser purchases....big buys. This one I'm putting in my closet for next year. Almost have 100,000 shares. Now RNVA you have to watch everyday.....never know when shameless will pull the plug....GL man

This thing is taking the shitzzzz Rnva is a way better buy

Thanks for all the cheapies fellas.....now wait time. Back to $4 sometime this spring. All I have is time !